Clinical effects of GB-115 in patients with Generalized Anxiety Disorder
Observational study · 2022
- What was studied
- 25 patients; uncontrolled conference report
- Main finding
- A conference post-hoc analysis of 25 patients reported lower anxiety and fatigue scores over 21 days. Its relationship to the earlier pilot must be resolved before treating it as independent evidence.
Study data at a glance
- Participants or experimental model
- 25 patients; uncontrolled conference report
- Reported results
- A conference post-hoc analysis of 25 patients reported lower anxiety and fatigue scores over 21 days. Its relationship to the earlier pilot must be resolved before treating it as independent evidence.
Study limitations and source details
Study limitations
- Conference abstract, not a full clinical report.
- No placebo comparison; possible overlap with the 31-patient pilot.
Related publications may describe some of the same participants or experiments.
Source details
Conference abstract
Selected original-source text checked; full methodological review pending.
Selected text reviewed
Sources checked
Citation
Author unconfirmed. Clinical effects of GB-115 in patients with Generalized Anxiety Disorder European Psychiatry. 65(Suppl 1):S388
Study source ↗ · DOI 10.1192/j.eurpsy.2022.981 · Bibliography entry · Link to this summary